Search - tctmd.com

Displaying 1 - 10 of 10

Sort: Relevancy | Date

Presentation JIM 2018

Case: 57-year old man with known Alport syndrome: dialysis from age 17-years

Presenter: Azeem Latib

February 21, 2018

Presentation ISET 2016

Drug-Coated Balloons for Renal FMD

Presenter: Fabrizio Fanelli

February 09, 2016

Presentation

Choice of eGFR Equation Impacts Drug-Dosing Recommendations and Risk Stratification in CKD Patients Undergoing PCI

Presenter: J. Parsh

June 26, 2015

Presentation CADECI 2015

Donde estamos en la denervación renal, después del estudio SYMPLICITY 3

Presenter: Dr. Juan Gaspar

February 19, 2015

Presentation ISET 2015

Endovascular Therapy in the Management of Hypertension

Presenter: Barry T. Katzen

January 30, 2015

$Symplicity Flex: A Prospective, Randomized, Sham-Controlled Trial of Renal Sympathetic Denervation in Patients with Mild Refractory Hypertension$

Presentation TCT 2014

Symplicity Flex: A Prospective, Randomized, Sham-Controlled Trial of Renal Sympathetic Denervation in Patients with Mild Refractory Hypertension

Presenter: Ajay J. Kirtane, Deepak L. Bhatt, Steffen Desch

September 16, 2014

Presentation TCT 2013

Moving Away From Surrogate Measures: Rationale and Design for a Clinical Outcomes Trial of Renal Artery Denervation (EnligHTNment)

Presenter: Felix Mahfoud

October 27, 2013

Presentation TCT 2013

Is Urinary Neutrophil Gelatinase-Associated Lipocalin the “Renal Troponin” in Invasive Cardiology?

Presenter: Tilman Perrin, Eric Descombes, St?phanie Gobet, Jean-Luc Magnin, Magali Gachet, Ould Hemett, Daniel Hayoz, Val?rie Stolt, G?rard Baeriswyl, Jean-Christophe Stauffer, Jean-Jacques Goy, Mario Togni, St?phane Cook

January 31, 2013

Presentation TCT 2012

SYMPLICITY Results Are Too Good to Be True: That's Why We Need a Sham Trial Design!

Presenter: Darrel Francis

October 24, 2012

Presentation TCT 2012

DES for Vascular Erectile Dysfunction: Follow-up from the ZEN First-in-Man Study

Presenter: Krishna Rocha-Singh

October 22, 2012

Advertisement

Case: 57-year old man with known Alport syndrome: dialysis from age 17-years

Drug-Coated Balloons for Renal FMD

Choice of eGFR Equation Impacts Drug-Dosing Recommendations and Risk Stratification in CKD Patients Undergoing PCI

Donde estamos en la denervación renal, después del estudio SYMPLICITY 3

Endovascular Therapy in the Management of Hypertension

Symplicity Flex: A Prospective, Randomized, Sham-Controlled Trial of Renal Sympathetic Denervation in Patients with Mild Refractory Hypertension

Moving Away From Surrogate Measures: Rationale and Design for a Clinical Outcomes Trial of Renal Artery Denervation (EnligHTNment)

Is Urinary Neutrophil Gelatinase-Associated Lipocalin the “Renal Troponin” in Invasive Cardiology?

SYMPLICITY Results Are Too Good to Be True: That's Why We Need a Sham Trial Design!

DES for Vascular Erectile Dysfunction: Follow-up from the ZEN First-in-Man Study

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content